Nicotine patch preloading for smoking cessation (the preloading trial): Study protocol for a randomized controlled trial

N. Lindson-Hawley, T. Coleman, G. Docherty, P. Hajek, S. Lewis, Deborah Lycett, A. McEwan, H. McRobbie, M.R. Munafò, S. Parrott, P. Aveyard

    Research output: Contribution to journalArticle

    7 Citations (Scopus)
    24 Downloads (Pure)

    Abstract

    Background: The use of nicotine replacement therapy before quitting smoking is called nicotine preloading. Standard smoking cessation protocols suggest commencing nicotine replacement therapy only on the first day of quitting smoking (quit day) aiming to reduce withdrawal symptoms and craving. However, other, more successful smoking cessation pharmacotherapies are used prior to the quit day as well as after. Nicotine preloading could improve quit rates by reducing satisfaction from smoking prior to quitting and breaking the association between smoking and reward. A systematic literature review suggests that evidence for the effectiveness of preloading is inconclusive and further trials are needed. Methods/Design: This is a study protocol for a multicenter, non-blinded, randomized controlled trial based in the United Kingdom, enrolling 1786 smokers who want to quit, funded by the National Institute for Health Research, Health Technology Assessment program, and sponsored by the University of Oxford. Participants will primarily be recruited through general practices and smoking cessation clinics, and randomized (1:1) either to use 21 mg nicotine patches, or not, for four weeks before quitting, whilst smoking as normal. All participants will be referred to receive standard smoking cessation service support. Follow-ups will take place at one week, four weeks, six months and 12 months after quit day. The primary outcome will be prolonged, biochemically verified six-month abstinence. Additional outcomes will include point prevalence abstinence and abstinence of four-week and 12-month duration, side effects, costs of treatment, and markers of potential mediators and moderators of the preloading effect. Discussion: This large trial will add substantially to evidence on the effectiveness of nicotine preloading, but also on its cost effectiveness and potential mediators, which have not been investigated in detail previously. A range of recruitment strategies have been considered to try and compensate for any challenges encountered in recruiting the large sample, and the multicentre design means that knowledge can be shared between recruitment teams. The pragmatic study design means that results will give a realistic estimate of the success of the intervention if it were to be rolled out as part of standard smoking cessation service practice. Trial registration: Current Controlled Trials ISRCTN33031001. Registered 27 April 2012.
    Original languageEnglish
    Article number296
    JournalTrials
    Volume15
    DOIs
    Publication statusPublished - 2014

    Fingerprint

    Tobacco Use Cessation Products
    Smoking Cessation
    Clinical Protocols
    Nicotine
    Randomized Controlled Trials
    Smoking
    Biomedical Technology Assessment
    Substance Withdrawal Syndrome
    National Institutes of Health (U.S.)
    Reward
    General Practice
    Health Care Costs
    Cost-Benefit Analysis
    Drug Therapy
    Therapeutics
    Research

    Bibliographical note

    Additional files can be found at http://www.trialsjournal.com/content/15/1/296/additional .
    This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

    Keywords

    • addiction
    • cessation
    • nicotine
    • preloading
    • quitting
    • smoking
    • tobacco
    • treatment

    Cite this

    Nicotine patch preloading for smoking cessation (the preloading trial): Study protocol for a randomized controlled trial. / Lindson-Hawley, N.; Coleman, T.; Docherty, G.; Hajek, P.; Lewis, S.; Lycett, Deborah; McEwan, A.; McRobbie, H.; Munafò, M.R.; Parrott, S.; Aveyard, P.

    In: Trials, Vol. 15, 296, 2014.

    Research output: Contribution to journalArticle

    Lindson-Hawley, N, Coleman, T, Docherty, G, Hajek, P, Lewis, S, Lycett, D, McEwan, A, McRobbie, H, Munafò, MR, Parrott, S & Aveyard, P 2014, 'Nicotine patch preloading for smoking cessation (the preloading trial): Study protocol for a randomized controlled trial' Trials, vol. 15, 296. https://doi.org/10.1186/1745-6215-15-296
    Lindson-Hawley, N. ; Coleman, T. ; Docherty, G. ; Hajek, P. ; Lewis, S. ; Lycett, Deborah ; McEwan, A. ; McRobbie, H. ; Munafò, M.R. ; Parrott, S. ; Aveyard, P. / Nicotine patch preloading for smoking cessation (the preloading trial): Study protocol for a randomized controlled trial. In: Trials. 2014 ; Vol. 15.
    @article{2b1b695f43b347e6b2329d448af6ef00,
    title = "Nicotine patch preloading for smoking cessation (the preloading trial): Study protocol for a randomized controlled trial",
    abstract = "Background: The use of nicotine replacement therapy before quitting smoking is called nicotine preloading. Standard smoking cessation protocols suggest commencing nicotine replacement therapy only on the first day of quitting smoking (quit day) aiming to reduce withdrawal symptoms and craving. However, other, more successful smoking cessation pharmacotherapies are used prior to the quit day as well as after. Nicotine preloading could improve quit rates by reducing satisfaction from smoking prior to quitting and breaking the association between smoking and reward. A systematic literature review suggests that evidence for the effectiveness of preloading is inconclusive and further trials are needed. Methods/Design: This is a study protocol for a multicenter, non-blinded, randomized controlled trial based in the United Kingdom, enrolling 1786 smokers who want to quit, funded by the National Institute for Health Research, Health Technology Assessment program, and sponsored by the University of Oxford. Participants will primarily be recruited through general practices and smoking cessation clinics, and randomized (1:1) either to use 21 mg nicotine patches, or not, for four weeks before quitting, whilst smoking as normal. All participants will be referred to receive standard smoking cessation service support. Follow-ups will take place at one week, four weeks, six months and 12 months after quit day. The primary outcome will be prolonged, biochemically verified six-month abstinence. Additional outcomes will include point prevalence abstinence and abstinence of four-week and 12-month duration, side effects, costs of treatment, and markers of potential mediators and moderators of the preloading effect. Discussion: This large trial will add substantially to evidence on the effectiveness of nicotine preloading, but also on its cost effectiveness and potential mediators, which have not been investigated in detail previously. A range of recruitment strategies have been considered to try and compensate for any challenges encountered in recruiting the large sample, and the multicentre design means that knowledge can be shared between recruitment teams. The pragmatic study design means that results will give a realistic estimate of the success of the intervention if it were to be rolled out as part of standard smoking cessation service practice. Trial registration: Current Controlled Trials ISRCTN33031001. Registered 27 April 2012.",
    keywords = "addiction, cessation, nicotine, preloading, quitting, smoking, tobacco, treatment",
    author = "N. Lindson-Hawley and T. Coleman and G. Docherty and P. Hajek and S. Lewis and Deborah Lycett and A. McEwan and H. McRobbie and M.R. Munaf{\`o} and S. Parrott and P. Aveyard",
    note = "Additional files can be found at http://www.trialsjournal.com/content/15/1/296/additional . This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.",
    year = "2014",
    doi = "10.1186/1745-6215-15-296",
    language = "English",
    volume = "15",
    journal = "Trials",
    issn = "1745-6215",
    publisher = "Springer Verlag",

    }

    TY - JOUR

    T1 - Nicotine patch preloading for smoking cessation (the preloading trial): Study protocol for a randomized controlled trial

    AU - Lindson-Hawley, N.

    AU - Coleman, T.

    AU - Docherty, G.

    AU - Hajek, P.

    AU - Lewis, S.

    AU - Lycett, Deborah

    AU - McEwan, A.

    AU - McRobbie, H.

    AU - Munafò, M.R.

    AU - Parrott, S.

    AU - Aveyard, P.

    N1 - Additional files can be found at http://www.trialsjournal.com/content/15/1/296/additional . This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

    PY - 2014

    Y1 - 2014

    N2 - Background: The use of nicotine replacement therapy before quitting smoking is called nicotine preloading. Standard smoking cessation protocols suggest commencing nicotine replacement therapy only on the first day of quitting smoking (quit day) aiming to reduce withdrawal symptoms and craving. However, other, more successful smoking cessation pharmacotherapies are used prior to the quit day as well as after. Nicotine preloading could improve quit rates by reducing satisfaction from smoking prior to quitting and breaking the association between smoking and reward. A systematic literature review suggests that evidence for the effectiveness of preloading is inconclusive and further trials are needed. Methods/Design: This is a study protocol for a multicenter, non-blinded, randomized controlled trial based in the United Kingdom, enrolling 1786 smokers who want to quit, funded by the National Institute for Health Research, Health Technology Assessment program, and sponsored by the University of Oxford. Participants will primarily be recruited through general practices and smoking cessation clinics, and randomized (1:1) either to use 21 mg nicotine patches, or not, for four weeks before quitting, whilst smoking as normal. All participants will be referred to receive standard smoking cessation service support. Follow-ups will take place at one week, four weeks, six months and 12 months after quit day. The primary outcome will be prolonged, biochemically verified six-month abstinence. Additional outcomes will include point prevalence abstinence and abstinence of four-week and 12-month duration, side effects, costs of treatment, and markers of potential mediators and moderators of the preloading effect. Discussion: This large trial will add substantially to evidence on the effectiveness of nicotine preloading, but also on its cost effectiveness and potential mediators, which have not been investigated in detail previously. A range of recruitment strategies have been considered to try and compensate for any challenges encountered in recruiting the large sample, and the multicentre design means that knowledge can be shared between recruitment teams. The pragmatic study design means that results will give a realistic estimate of the success of the intervention if it were to be rolled out as part of standard smoking cessation service practice. Trial registration: Current Controlled Trials ISRCTN33031001. Registered 27 April 2012.

    AB - Background: The use of nicotine replacement therapy before quitting smoking is called nicotine preloading. Standard smoking cessation protocols suggest commencing nicotine replacement therapy only on the first day of quitting smoking (quit day) aiming to reduce withdrawal symptoms and craving. However, other, more successful smoking cessation pharmacotherapies are used prior to the quit day as well as after. Nicotine preloading could improve quit rates by reducing satisfaction from smoking prior to quitting and breaking the association between smoking and reward. A systematic literature review suggests that evidence for the effectiveness of preloading is inconclusive and further trials are needed. Methods/Design: This is a study protocol for a multicenter, non-blinded, randomized controlled trial based in the United Kingdom, enrolling 1786 smokers who want to quit, funded by the National Institute for Health Research, Health Technology Assessment program, and sponsored by the University of Oxford. Participants will primarily be recruited through general practices and smoking cessation clinics, and randomized (1:1) either to use 21 mg nicotine patches, or not, for four weeks before quitting, whilst smoking as normal. All participants will be referred to receive standard smoking cessation service support. Follow-ups will take place at one week, four weeks, six months and 12 months after quit day. The primary outcome will be prolonged, biochemically verified six-month abstinence. Additional outcomes will include point prevalence abstinence and abstinence of four-week and 12-month duration, side effects, costs of treatment, and markers of potential mediators and moderators of the preloading effect. Discussion: This large trial will add substantially to evidence on the effectiveness of nicotine preloading, but also on its cost effectiveness and potential mediators, which have not been investigated in detail previously. A range of recruitment strategies have been considered to try and compensate for any challenges encountered in recruiting the large sample, and the multicentre design means that knowledge can be shared between recruitment teams. The pragmatic study design means that results will give a realistic estimate of the success of the intervention if it were to be rolled out as part of standard smoking cessation service practice. Trial registration: Current Controlled Trials ISRCTN33031001. Registered 27 April 2012.

    KW - addiction

    KW - cessation

    KW - nicotine

    KW - preloading

    KW - quitting

    KW - smoking

    KW - tobacco

    KW - treatment

    U2 - 10.1186/1745-6215-15-296

    DO - 10.1186/1745-6215-15-296

    M3 - Article

    VL - 15

    JO - Trials

    JF - Trials

    SN - 1745-6215

    M1 - 296

    ER -